BioMarin Pharmaceutical
BMRN
$79.65
Share price
-1.06%
Change (1 day)
-16.32%
Change (1 year)
Categories
Market capitalization of BioMarin Pharmaceutical (BMRN)
Market cap: $15.12 Billion
As of May 2024 BioMarin Pharmaceutical has a market cap of $15.12 Billion. This makes BioMarin Pharmaceutical the world's 1197th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BioMarin Pharmaceutical from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $15.12 B | -16.73% |
| 2023 | $18.16 B | -5.57% |
| 2022 | $19.23 B | 18.58% |
| 2021 | $16.22 B | 1.9% |
| 2020 | $15.91 B | 4.69% |
| 2019 | $15.20 B | 0.18% |
| 2018 | $15.17 B | -3.08% |
| 2017 | $15.66 B | 9.92% |
| 2016 | $14.24 B | -15.8% |
| 2015 | $16.92 B | 25.55% |
| 2014 | $13.47 B | 33.54% |
| 2013 | $10.09 B | 63.05% |
| 2012 | $6.18 B | 57.63% |
| 2011 | $3.92 B | 31.8% |
| 2010 | $2.97 B | 56.88% |
| 2009 | $1.89 B | 6.88% |
| 2008 | $1.77 B | -48.31% |
| 2007 | $3.43 B | 128.67% |
| 2006 | $1.50 B | 87.69% |
| 2005 | $0.80 B | 94.33% |
| 2004 | $0.41 B | -17.21% |
| 2003 | $0.49 B | 31.3% |
| 2002 | $0.37 B | -46.16% |
| 2001 | $0.70 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of BioMarin Pharmaceutical was reported to be:
$15.12 Billion
$15.12 Billion
$15.12 Billion
$15.12 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $125.27 B | 728.31% | 🇫🇷 France |
 Ultragenyx RARE | $3.40 B | -77.48% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.11 B | -99.22% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.41 B | -97.27% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $2.76 B | -81.73% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $1.94 B | -87.12% | 🇺🇸 USA |